Occupe actuellement des postes chez ESSA Pharma Inc, Five Prime Therapeutics Inc, Atreca Inc, Proteostasis Therapeutics Inc and Kezar Life Sciences Inc
Position | Company | Period |
---|---|---|
Director | ESSA Pharma Inc | 1 janvier 2016 - |
Independent Director | Five Prime Therapeutics Inc | 1 septembre 2010 - |
Independent Director | Atreca Inc | 1 octobre 2014 - |
Independent Director | Proteostasis Therapeutics Inc | 1 février 2016 - |
Independent Director | Kezar Life Sciences Inc | 1 novembre 2016 - |
Independent Director | Immune Design Corp | 1 mars 2014 - 2 avril 2019 |
Independent Director | ESSA Pharma Inc | 5 mars 2015 - 1 janvier 2016 |
Independent Director | Seagen Inc | 1 juin 2004 - 16 mai 2014 |
Director | Lineage Cell Therapeutics Inc | 13 mai 2013 - 21 mars 2014 |
Director | Asterias Biotherapeutics Inc | 1 juin 2013 - 21 mars 2014 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2023-11-22 | 2023-11-21 |
ESSA Pharma Inc
(EPIX)
|
A Achat |
23 259
+3.1%
5,73133 274 USD |
23 259 +3.1% | 5,73 | 133 274 USD | |
2023-11-16 | 2023-11-03 |
ESSA Pharma Inc
(EPIX)
|
A Achat |
16 471
+2.2%
5,9998 661 USD |
16 471 +2.2% | 5,99 | 98 661 USD | |
2023-01-05 | 2022-12-21 |
ESSA Pharma Inc
(EPIX)
|
V Vente |
34 334
-4.8%
2,4283 088 USD |
34 334 -4.8% | 2,42 | 83 088 USD | |
2023-01-05 | 2022-12-21 |
ESSA Pharma Inc
(EPIX)
|
V Vente |
37 889
-5.0%
2,4191 312 USD |
37 889 -5.0% | 2,41 | 91 312 USD | |
2023-01-05 | 2022-12-20 |
ESSA Pharma Inc
(EPIX)
|
V Vente |
43 617
-5.5%
2,53110 351 USD |
43 617 -5.5% | 2,53 | 110 351 USD | |
2023-01-05 | 2022-12-16 |
ESSA Pharma Inc
(EPIX)
|
V Vente |
50 000
-5.9%
2,67133 500 USD |
50 000 -5.9% | 2,67 | 133 500 USD | |
2023-01-05 | 2022-12-15 |
ESSA Pharma Inc
(EPIX)
|
V Vente |
50 000
-5.6%
2,86143 000 USD |
50 000 -5.6% | 2,86 | 143 000 USD | |
2023-01-05 | 2022-12-15 |
ESSA Pharma Inc
(EPIX)
|
V Vente |
32 000
-3.4%
2,9092 800 USD |
32 000 -3.4% | 2,90 | 92 800 USD | |
2023-01-05 | 2022-12-14 |
ESSA Pharma Inc
(EPIX)
|
V Vente |
25 000
-2.6%
3,0075 000 USD |
25 000 -2.6% | 3,00 | 75 000 USD | |
2022-11-23 | 2022-11-22 |
Rain Therapeutics Inc
(RAIN)
|
A Achat |
77 000
+8.3%
8,27636 790 USD |
77 000 +8.3% | 8,27 | 636 790 USD | |
2022-11-23 | 2022-11-21 |
Rain Therapeutics Inc
(RAIN)
|
A Achat |
45 000
+5.1%
7,80351 000 USD |
45 000 +5.1% | 7,80 | 351 000 USD | |
2022-11-15 | 2022-11-14 |
Atea Pharmaceuticals Inc
(AVIR)
|
V Vente |
16 166
-2.0%
5,1683 352 USD |
16 166 -2.0% | 5,16 | 83 352 USD | |
2022-11-15 | 2022-11-11 |
Atea Pharmaceuticals Inc
(AVIR)
|
V Vente |
25 500
-3.1%
5,15131 333 USD |
25 500 -3.1% | 5,15 | 131 333 USD | |
2022-11-14 | 2022-11-08 |
Rain Therapeutics Inc
(RAIN)
|
A Achat |
42 881
+5.1%
5,83249 996 USD |
42 881 +5.1% | 5,83 | 249 996 USD | |
2022-03-22 | 2022-03-21 |
Kezar Life Sciences Inc
(KZR)
|
A Achat |
20 000
+2.3%
14,77295 400 USD |
20 000 +2.3% | 14,77 | 295 400 USD | |
2022-03-22 | 2022-03-18 |
Kezar Life Sciences Inc
(KZR)
|
A Achat |
45 000
+5.4%
17,00765 000 USD |
45 000 +5.4% | 17,00 | 765 000 USD | |
2022-03-22 | 2022-03-18 |
Kezar Life Sciences Inc
(KZR)
|
A Achat |
15 000
+1.9%
15,96239 400 USD |
15 000 +1.9% | 15,96 | 239 400 USD | |
2021-04-27 | 2021-04-23 |
Rain Therapeutics Inc
(RAIN)
|
A Achat |
5 000
+4.2%
15,7878 900 USD |
5 000 +4.2% | 15,78 | 78 900 USD | |
2021-04-27 | 2021-04-23 |
Rain Therapeutics Inc
(RAIN)
|
A Achat |
120 000
+inf%
17,002 040 000 USD |
120 000 +inf% | 17,00 | 2 040 000 USD | |
2021-03-04 | 2021-02-22 |
ESSA Pharma Inc
(EPIX)
|
A Achat |
57 000
+6.3%
27,001 539 000 USD |
57 000 +6.3% | 27,00 | 1 539 000 USD | |
2020-11-03 | 2020-11-03 |
Atea Pharmaceuticals Inc
(AVIR)
|
A Achat |
41 666
+5.4%
24,00999 984 USD |
41 666 +5.4% | 24,00 | 999 984 USD | |
2020-06-11 | 2020-06-11 |
Kezar Life Sciences Inc
(KZR)
|
A Achat |
100 000
+14.6%
5,50550 000 USD |
100 000 +14.6% | 5,50 | 550 000 USD | |
2020-02-05 | 2020-02-04 |
Kezar Life Sciences Inc
(KZR)
|
A Achat |
120 846
+21.5%
2,60314 200 USD |
120 846 +21.5% | 2,60 | 314 200 USD | |
2013-08-22 | 2013-08-20 | A Achat |
500
+inf%
3,711 855 USD |
500 +inf% | 3,71 | 1 855 USD |